International Immunology, Vol. 13, No. 8, 1043-1052,
August 2001
© 2001 Japanese Society for Immunology
Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors
Cancer Research Unit, The Canberra Hospital, Canberra, ACT 2606, Australia
1 Department of Microbiology and Immunology, and the Cancer Research Institute, University of California San Francisco, CA 94143-0414, USA
Correspondence to: H. S. Warren
NK cells can co-express inhibitory and activating killer Ig-like receptors (KIR) recognizing the same HLA class I ligand. We present evidence from experiments with NK cells expressing both activating (KIR2DS2) and inhibitory (KIR2DL2 and KIR2DL3) receptors that the activating KIR can function without apparent interference from the inhibitory KIR. These studies used CD158b mAb that is equally reactive with KIR2DS2, KIR2DL2 and KIR2DL3. First, we show using plastic-immobilized CD158b mAb that the activating KIR2DS2 is stimulated, resulting in NK cell division and degranulation. Second, we show using soluble CD158b mAb and FcRII + P815 cells that high concentrations of CD158b mAb trigger the inhibitory KIR, whereas low concentrations stimulate the activating KIR2DS2 resulting in NK cell division and cytolysis. These results demonstrate that the activating KIR2DS2 can function on cells co-expressing the inhibitory KIR2DL2 and/or KIR2DL3, indicating the potential for independent function of activating KIR with natural ligand.
Keywords: cellular proliferation, cytotoxicity, killer Ig-like receptors, NK cells
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Zal, J. C. Kaski, J. P. Akiyu, D. Cole, G. Arno, J. Poloniecki, A. Madrigal, A. Dodi, and C. Baboonian Differential Pathways Govern CD4+CD28- T Cell Proinflammatory and Effector Responses in Patients with Coronary Artery Disease J. Immunol., October 15, 2008; 181(8): 5233 - 5241. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Trichet, C. Benezech, C. Dousset, M.-C. Gesnel, M. Bonneville, and R. Breathnach Complex Interplay of Activating and Inhibitory Signals Received by V{gamma}9V{delta}2 T Cells Revealed by Target Cell beta2-Microglobulin Knockdown J. Immunol., November 1, 2006; 177(9): 6129 - 6136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Poggi, S. Negrini, M. R. Zocchi, A.-M. Massaro, L. Garbarino, S. Lastraioli, L. Gargiulo, L. Luzzatto, and R. Notaro Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors Blood, October 1, 2005; 106(7): 2399 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Williams, A. R. Bateman, and S. I. Khakoo HANGING IN THE BALANCE: KIR and Their Role in Disease Mol. Interv., August 1, 2005; 5(4): 226 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vitale, S. Carlomagno, M. Falco, D. Pende, E. Romeo, P. Rivera, M. D. Chiesa, D. Mavilio, and A. Moretta Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2 Int. Immunol., October 1, 2004; 16(10): 1459 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Spaggiari, P. Contini, A. Dondero, R. Carosio, F. Puppo, F. Indiveri, M. R. Zocchi, and A. Poggi Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction Blood, December 1, 2002; 100(12): 4098 - 4107. [Abstract] [Full Text] [PDF] |
||||



